Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product that has simultaneously sparked high hopes and ...
News Medical on MSN8h
Breakthrough in gene-editing with Cas12a for modeling human diseasesAustralian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.
The developer of the chatbot that shocked U.S. incumbents had access to Nvidia chips that its parent company providentially ...
Leaders of the top 3D printer manufacturers are confident their companies can help America reshore manufacturing.
A $10.3 million grant from the California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency, will fund ...
Little information has emerged about osavampator, a potentially first-in-class drug, since its promising Phase II performance last spring.
Interesting Engineering on MSN20h
Research exposes DeepSeek’s AI training cost is not $6M, it’s a staggering $1.3BSemiAnalysis debunks the $6 million DeepSeek AI training cost myth, revealing a massive $1.3 billion investment in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback